Cargando…
Does tirofiban prevent platelet loss in patients after cardiogenic shock during continuous renal replacement therapy?
Link and colleagues present a pilot study investigating platelet function and platelet numbers in patients with cardiogenic shock and acute kidney failure undergoing continuous venovenous haemodialysis. Their data indicate a significantly reduced platelet loss with combined therapy of unfractionated...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646330/ https://www.ncbi.nlm.nih.gov/pubmed/19040776 http://dx.doi.org/10.1186/cc7083 |